Clinical Trial Update: Reversing Glucose and Lipid-mediated Vascular Dysfunction [EARLY_Phase 1]

View source ↗

Summary

An early phase 1 clinical trial update on reversing glucose- and lipid-mediated vascular dysfunction in hypertension. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Blood Pressure, Hypertension | EARLY_Phase 1 | Status: RECRUITING